BioTrove, Inc. Purchases Through Hole Array Intellectual Property Portfolio from Genencor International Inc.Business Editors/Health/Medical Writers BIOWIRE2K WOBURN, Mass.--(BUSINESS WIRE)--Sept. 29, 2003 Purchase strengthens BioTrove's IP position in through-hole array technology BioTrove, Inc. today announced the purchase of an intellectual property portfolio covering through-hole array technology from Genencor International Inc. (GCOR). The portfolio includes several issued patents and multiple patent filings in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and overseas. The issued and pending claims augments and strengthens BioTrove's existing through-hole array patent portfolio with new method and device claims. BioTrove employs a through-hole array technology for its Living Chip(TM) platform, a massively parallel See MPP. liquid handling system of nanoliter samples for genomic genomic pertaining to a genome. genomic clone see clone. genomic DNA the DNA sequences making up the genome of an individual. genomic library see gene bank. , proteomic and high throughput screening and storage applications. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Dr. Colin J.H. Brenan, President and Chief Executive Officer of BioTrove, "BioTrove has greatly strengthened its competitive position in nanofluidic through-hole array technology with the purchase of the GCOR IP portfolio. We are poised to become the leader in nanofluidic technology for the life sciences." About BioTrove, Inc. BioTrove, Inc. is a privately held, biotechnology company focused on leveraging revolutionary micro- and nano-scale engineering solutions to overcome current bottlenecks in pharmaceutical drug discovery and biotechnology. BioTrove has two core nanofluidic platforms: the Living Chip(TM) and Momentum(TM) Ultra-High Throughput Mass Spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. . BioTrove offers assay development and screening services based on the core technology as well as advanced instrumentation instrumentation, in music: see orchestra and orchestration. instrumentation In technology, the development and use of precise measuring, analysis, and control equipment. to partners. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion